Provided by Tiger Fintech (Singapore) Pte. Ltd.

INCANNEX HEALTHCARE LTD

0.1793
+0.00030.17%
Post-market: 0.18000.0007+0.39%19:59 EDT
Volume:11.10M
Turnover:1.99M
Market Cap:5.28M
PE:-0.15
High:0.1841
Open:0.1790
Low:0.1700
Close:0.1790
Loading ...

Press Release: Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Dow Jones
·
03 Jun

Incannex Healthcare Inc. Advances to Phase 3 Clinical Trial for IHL-42X in Obstructive Sleep Apnea Treatment, Following FDA Authorization

Reuters
·
29 May

BRIEF-Incannex Healthcare Advances IHL-42X Reposa Trial To Phase 3 Following FDA Protocol Clearance

Reuters
·
29 May

Incannex Healthcare Inc. Advances Ihl-42X Reposa Trial to Phase 3 Following FDA Protocol Clearance

THOMSON REUTERS
·
29 May

Stonegate Capital Partners Updates Coverage on Incannex Healthcare, Highlights Cost Savings and Financial Improvements

Reuters
·
29 May

Incannex Healthcare Cancels Series A Warrants, Eliminates Potential Dilution of 347 Million Shares Ahead of Key Trial Results

Reuters
·
28 May

Incannex Healthcare Inc - Increases Shares Issuable Under Amended & Restated Sales Agreement to $50 Mln - SEC Filing

THOMSON REUTERS
·
28 May

Incannex Healthcare Inc. Expands Share Issuance Program with Amended Sales Agreement, Adds $50 Million in Common Stock

Reuters
·
28 May

Incannex Healthcare Announces Strategic Warrant Cancellation to Reduce Potential Dilution and Enhance Shareholder Value

Reuters
·
20 May

Incannex Healthcare Inc. Expands Share Issuance Agreement to $2.5 Million Under Sales Agreement with A.G.P/Alliance Global Partners

Reuters
·
20 May

Incannex Healthcare Announces Potential 50% Reduction in Series A Warrants to Minimize Stockholder Dilution

Reuters
·
16 May

Incannex Healthcare Inc. Announces New Agreement with Warrant Holders, Reducing Series A Warrants in Exchange for Up to $12.5 Million in Net Proceeds

Reuters
·
16 May

Incannex Healthcare Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Incannex reports Q3 EPS (20c) vs. (38c) last year

TIPRANKS
·
15 May

Incannex Healthcare Q3 EPS $(0.20) Up From $(0.38) YoY

Benzinga
·
15 May

Incannex Healthcare Reports Q3 2025 Financials: Net Loss Narrows to $3.97M, Cash Reserves Surge to $6.71M

Reuters
·
15 May

Press Release: Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

Dow Jones
·
15 May

Dow Edges Higher; US Crude Oil Inventories Increase

Benzinga
·
15 May

Incannex Completes Phase 2 Dosing in Sleep Apnea Drug Trial; Shares Jump

MT Newswires Live
·
14 May

Incannex Healthcare Announces Completion of Patient Dosing in Phase 2/3 Study for Promising OSA Treatment IHL-42X, Topline Results Expected July 2025

Reuters
·
14 May